Sign up for the QMED & MD+DI Daily newsletter.
Medtronic Wins $250 Million in Case Against Boston Scientific
A federal jury has found that Boston Scientific Corp. must pay Medtronic Inc. $250 million for infringing on three patents related to catheters. Medtronic sued the company in 2006, stating that Boston Scientific's Taxus Express2, Express2, Liberte, Maverick, Maverick2, and Quantum Maverick devices infringed on its Fitzmaurice and Anderson catheter patents.
May 28, 2008
1 Min Read
The Fitzmaurice patent involves angioplasty catheters that have narrowed distal ends to aid in delivering the catheter, and the Anderson patent concerns semicompliant angioplasty balloons that can withstand repeated inflations (for custom vessel sizing).Since the jury decided that the infringement was intentional, the judge can raise the award to $750 million. A Medtronic spokesperson said that the company might even seek an injunction to stop the sales of the infringing products.
You May Also Like
Masimo Takes Apple's Hail Mary Pass in StrideFeb 29, 2024|3 Min Read
Top 40 Medical Device CompaniesFeb 29, 2024|2 Min Read
2024 Planning Guide for Medical Manufacturing AutomationFeb 29, 2024|1 Min Read
Adverse Events Reported for Hologic BioZorb Marker, BioZorb LP MarkerFeb 28, 2024|2 Min Read